Entera Bio Ltd. (ENTX)
Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting
Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting
aTyr Pharma to be Added to the Russell2000® and Russell 3000® Indexes
McKesson Corporation - McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date
Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards
Positive Preliminary Cohort B Results from the AGITG-led ASCEND Trial to be Presented at ESMO GI Evaluating Lisata’sCertepetide in Combination with Standard-of-Care Chemotherapy in Metastatic Pancreatic Cancer
Montauk Brewing Celebrates 13 Years of Brewing with Faherty Collaboration and Beach Clean Up with the Surfrider Foundation
Artelo Biosciences Announces $1.425 Million At-the-Market Private Placement Financing
GRI Bios GRI-0621 Demonstrates Encouraging Safety Results at Planned Interim 6-Week Analysis in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF")
NanoVibronix Inc Notification (NAOV)
Lipocine Announces First Patient Dosed in Phase 3 Clinical Trial for LPCN 1154 in Postpartum Depression